OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry
Marco Dauriz, Giovanni Targher, Cécile Laroche, et al.
Diabetes Care (2017) Vol. 40, Iss. 5, pp. 671-678
Open Access | Times Cited: 119
Marco Dauriz, Giovanni Targher, Cécile Laroche, et al.
Diabetes Care (2017) Vol. 40, Iss. 5, pp. 671-678
Open Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 255-323
Open Access | Times Cited: 4103
Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 255-323
Open Access | Times Cited: 4103
Global burden of heart failure: a comprehensive and updated review of epidemiology
Gianluigi Savarese, Peter Moritz Becher, Lars H. Lund, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3272-3287
Open Access | Times Cited: 1478
Gianluigi Savarese, Peter Moritz Becher, Lars H. Lund, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3272-3287
Open Access | Times Cited: 1478
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 651
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 651
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Mark C. Petrie, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 853-872
Open Access | Times Cited: 587
Petar Seferović, Mark C. Petrie, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 853-872
Open Access | Times Cited: 587
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Circulation (2019) Vol. 140, Iss. 7
Open Access | Times Cited: 490
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Circulation (2019) Vol. 140, Iss. 7
Open Access | Times Cited: 490
Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults
Sridharan Raghavan, Jason L. Vassy, Yuk‐Lam Ho, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 411
Sridharan Raghavan, Jason L. Vassy, Yuk‐Lam Ho, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 411
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
Toshiaki Ohkuma, Yuji Komorita, Sanne A. E. Peters, et al.
Diabetologia (2019) Vol. 62, Iss. 9, pp. 1550-1560
Open Access | Times Cited: 213
Toshiaki Ohkuma, Yuji Komorita, Sanne A. E. Peters, et al.
Diabetologia (2019) Vol. 62, Iss. 9, pp. 1550-1560
Open Access | Times Cited: 213
The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 11, pp. 1402-1411
Open Access | Times Cited: 188
John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 11, pp. 1402-1411
Open Access | Times Cited: 188
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Kåre I. Birkeland, Johan Bodegård, Jan W. Eriksson, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 9, pp. 1607-1618
Open Access | Times Cited: 159
Kåre I. Birkeland, Johan Bodegård, Jan W. Eriksson, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 9, pp. 1607-1618
Open Access | Times Cited: 159
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure
Petar Seferović, Andrew J.S. Coats, Piotr Ponikowski, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 2, pp. 196-213
Open Access | Times Cited: 155
Petar Seferović, Andrew J.S. Coats, Piotr Ponikowski, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 2, pp. 196-213
Open Access | Times Cited: 155
Epidemiology of heart failure in diabetes: a disease in disguise
Anna G. Hoek, Elisa Dal Canto, Eva Wenker, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 574-601
Open Access | Times Cited: 15
Anna G. Hoek, Elisa Dal Canto, Eva Wenker, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 574-601
Open Access | Times Cited: 15
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure
John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli, et al.
JACC Heart Failure (2017) Vol. 6, Iss. 1, pp. 8-17
Open Access | Times Cited: 158
John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli, et al.
JACC Heart Failure (2017) Vol. 6, Iss. 1, pp. 8-17
Open Access | Times Cited: 158
Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Gabriele Fragasso, Mark C. Petrie, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1495-1503
Open Access | Times Cited: 122
Petar Seferović, Gabriele Fragasso, Mark C. Petrie, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1495-1503
Open Access | Times Cited: 122
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 120
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 120
Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis
Marco Dauriz, Alessandro Mantovani, Stefano Bonapace, et al.
Diabetes Care (2017) Vol. 40, Iss. 11, pp. 1597-1605
Open Access | Times Cited: 97
Marco Dauriz, Alessandro Mantovani, Stefano Bonapace, et al.
Diabetes Care (2017) Vol. 40, Iss. 11, pp. 1597-1605
Open Access | Times Cited: 97
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Predicting and preventing heart failure in type 2 diabetes
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 35
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 35
Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis
Rami Aldafas, Thomas Crabtree, Mohammed Alkharaiji, et al.
Age and Ageing (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 13
Rami Aldafas, Thomas Crabtree, Mohammed Alkharaiji, et al.
Age and Ageing (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 13
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure
Giovanna Gallo, Massimo Volpe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2484-2484
Open Access | Times Cited: 10
Giovanna Gallo, Massimo Volpe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2484-2484
Open Access | Times Cited: 10
Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways
Michaël Joubert, Alain Manrique, Bertrand Cariou, et al.
Diabetes & Metabolism (2018) Vol. 45, Iss. 3, pp. 238-247
Open Access | Times Cited: 68
Michaël Joubert, Alain Manrique, Bertrand Cariou, et al.
Diabetes & Metabolism (2018) Vol. 45, Iss. 3, pp. 238-247
Open Access | Times Cited: 68
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 9, pp. 1287-1305
Open Access | Times Cited: 7
Stephan von Haehling, Birgit Aßmus, Tarek Bekfani, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 9, pp. 1287-1305
Open Access | Times Cited: 7
Chapter 1: The Burden of Heart Failure
Richard E. Pratley, Xuan Guan, Richard J. Moro, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 2, pp. S3-S8
Open Access | Times Cited: 6
Richard E. Pratley, Xuan Guan, Richard J. Moro, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 2, pp. S3-S8
Open Access | Times Cited: 6
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
Alaaeldin Bashier, Azza Bin Hussain, Elamin Abdelgadir, et al.
Diabetology & Metabolic Syndrome (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Alaaeldin Bashier, Azza Bin Hussain, Elamin Abdelgadir, et al.
Diabetology & Metabolic Syndrome (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
Michele Correale, Stefania Paolillo, Valentina Mercurio, et al.
European Journal of Internal Medicine (2019) Vol. 71, pp. 23-31
Closed Access | Times Cited: 43
Michele Correale, Stefania Paolillo, Valentina Mercurio, et al.
European Journal of Internal Medicine (2019) Vol. 71, pp. 23-31
Closed Access | Times Cited: 43
Prognosis of chronic Chagas heart disease and other pending clinical challenges
Rosália Morais Tôrres, Dalmo Correia, Maria do Carmo Pereira Nunes, et al.
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 26
Rosália Morais Tôrres, Dalmo Correia, Maria do Carmo Pereira Nunes, et al.
Memórias do Instituto Oswaldo Cruz (2022) Vol. 117
Open Access | Times Cited: 26
